tirzepatide vs. semaglutide Semaglutide: Understanding Your Weight Loss Medication Options Tirzepatide vs. Semaglutide: Which is

Eur J Heart Fail 24(10):19061914

CMS has recently announced an indefinite delay in implementation of the BALANCE Model, however, and an extension of the GLP-1 Bridge through the end of 2027 (as described below)

Novo Nordisks semaglutide, marketed as Wegovy for people with obesity and Ozempic for those with Type 2 diabetes, has been on the FDA Drug Shortages list since August 2022

In one of two recently published studies in JAMA Neurology , Allie Seminer , MSc , and Alfredi Mulihano , undergraduate students in the School of Medicine at the University of Galway in Ireland, and colleagues found that GLP-1 receptor agonists significantly reduced the risk for all-cause dementia, but SGLT2 inhibitors did not

Lowering the dose for a few weeks or slowing the schedule can help minimize side effects, making the medicine easier to stick with

Type 2 diabetes Treatment summaries, BNF NICE